Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon cancer.

Study ID: 2965
NCT Number: NCT05174169
Principal Investigator: Ruobing Xue, MD
Department: Medicine-Hematology & Oncology
Eligibility: Both men and women 18 years old to 100 years old. Does not accept healthy volunteers.

For questions about this study, please contact:

CancerClinicalTrials@health.missouri.edu